Vogenx Inc (VOGX)

Currency in USD
12.81
+0.46(+3.73%)
Closed·
12.810.00(0.00%)
·
Trading near 52-week Low
VOGX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.5112.85
52 wk Range
11.5138.41
Key Statistics
Prev. Close
12.81
Open
12.5
Day's Range
11.51-12.85
52 wk Range
11.51-38.41
Volume
144.36K
Average Volume (3m)
133.81K
1-Year Change
-
Book Value / Share
NA
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VOGX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
55.00
Upside
+329.35%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Vogenx Inc News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 55.00
(+329.35% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
WBB Securities
Buy---New CoverageSep 02, 2026

Earnings

Latest Release
Nov 06, 2026
EPS / Forecast
-0.47 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

VOGX Income Statement

Compare VOGX to Peers and Sector

Metrics to compare
VOGX
Peers
Sector
Relationship
P/E Ratio
−115.0x−1.3x−0.2x
PEG Ratio
-−0.470.00
Price/Book
−106.9x1.2x2.6x
Price / LTM Sales
-2.8x2.7x
Upside (Analyst Target)
329.4%92.1%72.2%
Fair Value Upside
Unlock16.4%12.4%Unlock

Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
111.72K0.75%1.38M
Other Institutional Investors
4.20M28.28%51.84M
Public Companies & Retail Investors
10.54M70.97%130.10M
Total
14.86M100.00%183.31M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Janus Henderson Group Ltd.12.95%1,923,07623,731
Janus Henderson Biotech Innovation Master Fund Limited12.95%1,923,07623,731

People Also Watch

13.22
SCTX
-5.91%
17.25
APMD
-1.15%
19.27
BRVE
+3.99%
13.24
LTGO
-0.53%

FAQ

What Is the Vogenx (VOGX) Stock Price Today?

The Vogenx stock price today is 12.81 USD.

What Stock Exchange Does Vogenx Trade On?

Vogenx is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Vogenx?

The stock symbol for Vogenx is "VOGX."

What Is the Vogenx Market Cap?

As of today, Vogenx market cap is 190.22M USD.

What Is Vogenx's Earnings Per Share (TTM)?

The Vogenx EPS (TTM) is -0.30.

From a Technical Analysis Perspective, Is VOGX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Vogenx Stock Split?

Vogenx has split 0 times.

How Many Employees Does Vogenx Have?

Vogenx has 5 employees.

What is the current trading status of Vogenx (VOGX)?

As of Nov 20, 2026, Vogenx (VOGX) is trading at a price of 12.81 USD, with a previous close of 12.81 USD. The stock has fluctuated within a day range of 11.51 USD to 12.85 USD, while its 52-week range spans from 11.51 USD to 38.41 USD.

What Is Vogenx (VOGX) Price Target According to Analysts?

The average 12-month price target for Vogenx is 55.00 USD, with a high estimate of 55 USD and a low estimate of 55 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +329.35% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.